Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis

Summary

This is a randomized, double-blind study of excimer (308-nm UVB) laser added to either tazarotene 0.1% gel or acitretin 25 mg daily for plaque psoriasis. The primary objective of this study is to compare the improvement of psoriatic plaques with and without excimer laser (308-nm UVB) treatment, applied in a randomized and blinded fashion, in subjects on acitretin 25 mg or tazarotene gel 0.1% QD.

Timeline

Start

2010-01

Primary completion

2011-09

Completion

2011-10

Drugs

Indications